• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN (IRVINE) PIPELINE EMBOLIZATION DEVICE INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Device Problems Migration or Expulsion of Device (1395); Difficult To Position (1467)
Patient Problems Intracranial Hemorrhage (1891); Neurological Deficit/Dysfunction (1982); Occlusion (1984); Paresis (1998)
Event Date 03/09/2017
Event Type  Injury  
Manufacturer Narrative
Peschillo, s. , caporlingua, a. , resta, m. C. , peluso, j. P. , burdi, n. , sourour, n. ,. Resta, m. (2017). Endovascular treatment of large and giant carotid aneurysms with flow-diverter stents alone or in combination with coils: a multicenter experience and long-term follow-up. Operative neurosurgery, 13(4), 492-502. Doi:10. 1093/ons/opx032 the pipeline devices have not been returned for evaluation; product analysis cannot be performed. The devices were not returned; the reported events could not be confirmed. The cause of the events could not be conclusively determined from the provided information. Mdrs related to this article: 2029214-2018-00292 2029214-2018-00293. If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic literature review found reports of intraoperative or post-operative pipeline (ped) complications. The purpose of this article was to evaluate the risk of complications after flow diverter treatment vs. Flow diverter + coil treatment of large/giant internal carotid artery (ica) aneurysms. The authors reviewed 44 patients with large or giant ica aneurysms: 26 patients underwent treatment using flow diverters (fd) alone and 18 patients underwent treatment using fd + coils. Of the 44 patients, 12 were male and 32 were female; mean age was 58. 3 years. The article states that the following intraoperative or post-operative complications occurred: in case 3, the patient ((b)(6) male) underwent placement of a ped and another manufacturer's fd in the treatment of a large, saccular supraclinoid aneurysm (16mm). The article states that intraoperative complications included aneurysmal rupture and fd deploy complication (the article does not specify which fd was involved). The patient's post-operative mrs was 4; one-year follow-up mrs was 3. In case 4, the patient ((b)(6) female) underwent placement of a ped in the treatment of a large, fusiform intracavernous aneurysm (20mm). The patient experienced post-operative hemiparesis. The patient's mrs was 5 post-operatively and was 1 one-year post-procedure. In case 39, the patient ((b)(6) female) underwent placement of two peds in the treatment of a giant, saccular intracavernous aneurysm (27mm). The article indicates that the patient experienced intraoprative fd deploy complication as well as parent artery stenoocclusion. Post-operatively, the patient experienced transient hemiparesis. The patient's mrs was 1 post-operatively and was 0 one year later. In case 42, the patient ((b)(6) female) underwent placement of a ped in the treatment of a large, saccular intracavernous aneurysm (22mm). The patient experienced intraoperative thromboembolism. In addition, the patient experienced post-operative transient hemiparesis. The patient's mrs was 2 post-operatively and was 0 one year later. In case 43, the patient ((b)(6) female) underwent placement of two peds in the treatment of a large, saccular intracavernous aneurysm (22mm). The patient experienced intraoperative fd deploy complication as well as thromboembolism. The patient's post-operative and one-year follow-up mrs were both 0. In case 44, the patient ((b)(6) female) underwent placement of a ped in the treatment of a large, saccular supraclinoid aneurysm (18mm). The patient experienced intraoperative thromboembolism as well as post-operative slight motor aphasia. The article states that the aphasia was likely due to fd-mediated occlusion of lenticulostriate artery/arteries. The patient's mrs post-operatively and one year later were both 2. The article states that deployment complications included accidental iatrogenic fd migration, intraaneurysmal fd migration, distal fd misplacement, and simple deployment difficulties without relevant repercussion. The article does not specify what type of deployment complication each patient experienced.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NamePIPELINE EMBOLIZATION DEVICE
Type of DeviceINTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
tricha miles
9775 toledo way
irvine, CA 92618
9496801224
MDR Report Key7441612
MDR Text Key105874832
Report Number2029214-2018-00292
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation
Type of Report Initial
Report Date 04/18/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/18/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received03/26/2018
Was Device Evaluated by Manufacturer? No Answer Provided
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 04/18/2018 Patient Sequence Number: 1
-
-